BioMe™ Biobank Program
Channeling the power of genomics and BIG data to elevate medical decision-making and optimize the customization of healthcare.

For pharmaceutical and biotech companies, drug development is multifaceted. For doctors, the administration of medical care is complex. For patients, undergoing the right treatment is decisive.

The Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai is leading the radical movement toward diagnoses & classification of disease according to the patient’s molecular profile, accommodating differences at all possible levels of exposure (genome + environment + lifestyle) and at all stages of the process, from prevention to post-treatment follow-up. Personalized medicine is what drives our Institute’s research.